Skip to main content

Table 2 Proportion of antibiotic resistance of five GLASS pathogens1 among populations in conflict and non-conflict affected Middle Eastern countries, described as percentage median resistance and interquartile range (IQR) of data reported in 116 articles

From: Antimicrobial resistance among GLASS pathogens in conflict and non-conflict affected settings in the Middle East: a systematic review

GLASS pathogen

Resistance profile of public health importance

Overall percentage median resistance

Percentage median resistance in conflict-affected countries

Percentage median resistance in non-conflict affected countries

References

(Total number of isolates)

(Total number of isolates tested)

(IQR)

(IQR)

(IQR)

Acinetobacter spp. (6′129)

Carbapenem-resistant (5′825)

74.23 (25.89–88.33)

78.00 (58.97–82.41)

72.73 (23.23–91.30)

[42, 46,47,48, 61, 63, 65, 68, 80, 83, 85, 88, 90, 92, 97, 99, 101, 104, 106, 108, 110, 115, 123, 124, 126, 131, 133,134,135, 138, 140, 153, 157, 167, 171, 172]

E. coli (41′472)

Carbapenem-resistant (36′116)

8.07 (0.54–25.34)

1.33 (0–7.58)

14.29 (5.00–50.00)

[42, 45, 47,48,49, 54, 59, 65, 67, 71, 75, 76, 87, 89, 91, 99, 105, 107, 109, 32, 6, 114,115,116,117, 119, 123, 128, 133, 143, 151, 155, 160, 166, 172]

ESBL-producing (35′655)

32.30 (21.75–50.93)

25.85 (14.99–48.43)

39.21 (27.75–51.94)

[45, 52, 54, 59, 62, 72, 73, 75, 76, 79, 105, 114, 117, 123, 135, 141, 154, 155, 159, 160, 164, 165]

K. pneumoniae (2′373)

Carbapenem resistant (1′341)

15.39 (2.03–24.67)

17.71 (9.94–26.56)

15.00 (1.21–20.18)

[42, 47, 69, 76, 84, 86, 92, 99, 104, 107, 112, 115,116,117,118, 145, 153, 155, 158, 160, 172]

ESBL-producing (1′013)

27.91 (20.39–66.03)

75.46 (70.42–80.49)

22.50 (19.65–38-10)

[52, 62, 72, 76, 117, 155, 158, 160, 164, 165]

S. aureus (8′886)

MRSA (8′403)

45.08 (25.96–61.57)

43.37 (28.11–59.42)

45.32 (24.44–61.42)

[41, 43, 44, 51,52,53, 55,56,57, 65, 66, 71, 74, 77, 78, 81, 95, 96, 102, 111, 116, 121, 123, 125, 128, 129, 133, 135, 136, 139, 144, 148, 150, 161, 163, 168, 170]

VRSA (6′170)

0 (0–10.20)

1.32 (0.08–3.84)

0 (0–16.67)

[44, 51, 65, 70, 71, 89, 95, 96, 103, 116, 123, 128, 133, 134, 139, 142, 144, 150, 168]

S. pneumoniae (1′766)

Penicillin non-susceptible (1′050)

50.00 (8.78–68.95)

10.90 (5.45–30.45)

55.00 (20.42–77.81)

[50, 64, 93, 99, 120, 127, 152, 156]

  1. 1 WHO. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2016–2017. Geneva, Switzerland; 2017